PTPI Valuation
Petros Pharmaceuticals Inc
$
0.000
- Overview
- Forecast
- Valuation
- Earnings
PTPI Relative Valuation
PTPI's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, PTPI is overvalued; if below, it's undervalued.
Historical Valuation
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
-0.01
P/B
Median3y
0.43
Median5y
0.63
-767.15
FCF Yield
Median3y
-230.86
Median5y
-162.98
Competitors Valuation Multiple
The average P/S ratio for PTPI's competitors is 0.15, providing a benchmark for relative valuation. Petros Pharmaceuticals Inc Corp (PTPI) exhibits a P/S ratio of , which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
People Also Watch
TRNR
Interactive Strength Inc
6.570
USD
+7.88%
QLGN
Qualigen Therapeutics Inc
3.000
USD
-2.28%
BCAN
BYND Cannasoft Enterprises Inc
4.200
USD
0.00%
SISI
Shineco Inc
0.167
USD
+3.08%
MTNB
Matinas BioPharma Holdings Inc
0.950
USD
-1.35%
SNES
Senestech Inc
5.590
USD
+27.05%
BQ
Boqii Holding Ltd
2.900
USD
+3.20%
SGD
Safe & Green Development Corp
0.902
USD
-1.42%
GNLN
Greenlane Holdings Inc
4.030
USD
+3.60%
SCNI
Scinai Immunotherapeutics Ltd
2.320
USD
+5.45%
FAQ
Is Petros Pharmaceuticals Inc (PTPI) currently overvalued or undervalued?
Petros Pharmaceuticals Inc (PTPI) is now in the Fair zone, suggesting that its current forward PS ratio of NaN is considered Fairly compared with the five-year average of -0.19. The fair price of Petros Pharmaceuticals Inc (PTPI) is between to according to relative valuation methord.
What is Petros Pharmaceuticals Inc (PTPI) fair value?
How does PTPI's valuation metrics compare to the industry average?
What is the current P/B ratio for Petros Pharmaceuticals Inc (PTPI) as of Jul 23 2025?
What is the current FCF Yield for Petros Pharmaceuticals Inc (PTPI) as of Jul 23 2025?
What is the current Forward P/E ratio for Petros Pharmaceuticals Inc (PTPI) as of Jul 23 2025?